These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568 [TBL] [Abstract][Full Text] [Related]
3. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy. Zhang Y; Liu Y; Liang L; Liu L; Tang X; Tang L; Chen P; Chen J; Wang Z; Cao W; Chen Q; Zhao N; Xu D Kidney Blood Press Res; 2020; 45(5):713-726. PubMed ID: 32894840 [TBL] [Abstract][Full Text] [Related]
4. Mannose-Binding Lectin Deposition in Membranous Nephropathy and Differentiation of Primary from Secondary Forms. Zdravkova I; Tilkiyan E; Bozhkova D Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062903 [TBL] [Abstract][Full Text] [Related]
5. Immunology of membranous nephropathy: from animal models to humans. Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967 [TBL] [Abstract][Full Text] [Related]
7. Complement activation products in the circulation and urine of primary membranous nephropathy. Zhang MF; Huang J; Zhang YM; Qu Z; Wang X; Wang F; Meng LQ; Cheng XY; Cui Z; Liu G; Zhao MH BMC Nephrol; 2019 Aug; 20(1):313. PubMed ID: 31399080 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection. Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634 [TBL] [Abstract][Full Text] [Related]
10. Mannose-Binding Lectin2 Gene Polymorphism and IgG4 in Membranous Nephropathy. Costa DMDN; Valente LM; Vajgel Fernandes G; Sandrin-Garcia P; da Cruz HLA; Crovella S; Cavalcante AHS; Cavalcante MAGM; de Oliveira CBL; de Vasconcelos CAJ; Sarinho ESC Nephron; 2018; 139(2):181-188. PubMed ID: 29439276 [TBL] [Abstract][Full Text] [Related]
11. M-type phospholipase A Kanda S; Horita S; Yanagihara T; Shimizu A; Hattori M Pediatr Nephrol; 2017 Apr; 32(4):713-717. PubMed ID: 27921164 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
13. IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study. Yang Y; Wang C; Jin L; He F; Li C; Gao Q; Chen G; He Z; Song M; Zhou Z; Shan F; Qi K; Ma L Immunol Res; 2016 Aug; 64(4):919-30. PubMed ID: 26837241 [TBL] [Abstract][Full Text] [Related]
14. Detection and clinical significance of glomerular M-type phospholipase A Liu H; Luo W; Gong S; Ding X Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390 [TBL] [Abstract][Full Text] [Related]
15. The role of complement in membranous nephropathy. Ma H; Sandor DG; Beck LH Semin Nephrol; 2013 Nov; 33(6):531-42. PubMed ID: 24161038 [TBL] [Abstract][Full Text] [Related]
16. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy. Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075 [TBL] [Abstract][Full Text] [Related]
17. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. Debiec H; Hanoy M; Francois A; Guerrot D; Ferlicot S; Johanet C; Aucouturier P; Godin M; Ronco P J Am Soc Nephrol; 2012 Dec; 23(12):1949-54. PubMed ID: 23123401 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981 [TBL] [Abstract][Full Text] [Related]
19. Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy. Huang B; Zhang Y; Wang L; Xu W; Zhang J; Zhang Q; Sheng H; Hu Z Kidney Blood Press Res; 2019; 44(4):848-857. PubMed ID: 31242492 [TBL] [Abstract][Full Text] [Related]
20. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]